Literature DB >> 23376486

Proteome changes associated with Leishmania donovani promastigote adaptation to oxidative and nitrosative stresses.

Abul Hasan Sardar1, Sudeep Kumar, Ashish Kumar, Bidyut Purkait, Sushmita Das, Abhik Sen, Manish Kumar, Kislay Kumar Sinha, Dharmendra Singh, Asif Equbal, Vahab Ali, Pradeep Das.   

Abstract

Phagocytic cells produce reactive oxygen and nitrogen species (ROS & RNS) as the most common arsenal to kill intracellular pathogens. Leishmania, an obligate intracellular pathogen also confronts this antimicrobial assault during the early phase of infection but nevertheless is able to survive these attacks and proliferate in macrophage. Adaptation of Leishmania to the toxic effects of ROS and RNS, involves a rapid change in the parasite proteome to combat the host defense response that macrophage mount in combating pathogen. To understand the events associated with combating ROS and RNS species, we performed a proteomic analysis of L. donovani promastigotes treated with sub-lethal doses of menadione (ROS), S-nitroso-N-acetylpenicillamine (RNS) or combination of both compounds. Proteomic changes triggered by these reagents were evaluated by iTRAQ labeling and subsequent LC-MALDI-TOF/TOF-MS analysis. Across the 3 stress conditions, the quantitative analysis identified changes in the proteins which encompass ~20% of the parasite proteome. Major changes were observed in enzymatic machinery of pathways involved in maintaining redox homeostasis, trypanothione metabolism, oxidative phosphorylation, superoxide metabolism, mitochondrial respiration process and other essential metabolic pathways. These observations shed light on how Leishmania promastigotes counter ROS and RNS effects during the initial stage of infection. This article is part of a Special Issue entitled: From protein structures to clinical applications.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23376486     DOI: 10.1016/j.jprot.2013.01.011

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  20 in total

1.  In Vitro Evaluation of Antileishmanial Activity of Computationally Screened Compounds against Ascorbate Peroxidase To Combat Amphotericin B Drug Resistance.

Authors:  Rani Mansuri; Ashish Kumar; Sindhuprava Rana; Bhavana Panthi; M Yousuf Ansari; Sushmita Das; Manas Ranjan Dikhit; Ganesh Chandra Sahoo; Pradeep Das
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

2.  Proteomic-based approach to gain insight into reprogramming of THP-1 cells exposed to Leishmania donovani over an early temporal window.

Authors:  Alok Kumar Singh; Rajeev Kumar Pandey; Jair Lage Siqueira-Neto; Yong-Jun Kwon; Lucio H Freitas-Junior; Chandrima Shaha; Rentala Madhubala
Journal:  Infect Immun       Date:  2015-02-17       Impact factor: 3.441

Review 3.  IRONy OF FATE: role of iron-mediated ROS in Leishmania differentiation.

Authors:  Bidyottam Mittra; Norma W Andrews
Journal:  Trends Parasitol       Date:  2013-08-12

4.  Leishmanicidal Activity of an In Silico-Screened Novel Inhibitor against Ascorbate Peroxidase of Leishmania donovani.

Authors:  Mohammad Kashif; Ankush Paladhi; Ranjeet Singh; Sankar Bhattacharyya; Sumit Kumar Hira; Partha Pratim Manna
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191

5.  Phosphorylation of Translation Initiation Factor 2-Alpha in Leishmania donovani under Stress Is Necessary for Parasite Survival.

Authors:  Kumar Abhishek; Abul Hasan Sardar; Sushmita Das; Ashish Kumar; Ayan Kumar Ghosh; Ruby Singh; Savita Saini; Abhishek Mandal; Sudha Verma; Ajay Kumar; Bidyut Purkait; Manas Ranjan Dikhit; Pradeep Das
Journal:  Mol Cell Biol       Date:  2016-12-19       Impact factor: 5.069

6.  Infection with Leishmania major induces a cellular stress response in macrophages.

Authors:  Alessandra A Filardy; Ana Caroline Costa-da-Silva; Carolina M Koeller; Kamila Guimarães-Pinto; Flávia L Ribeiro-Gomes; Marcela F Lopes; Norton Heise; Célio G Freire-de-Lima; Marise P Nunes; George A DosReis
Journal:  PLoS One       Date:  2014-01-09       Impact factor: 3.240

7.  Stage-dependent expression and up-regulation of trypanothione synthetase in amphotericin B resistant Leishmania donovani.

Authors:  Asif Equbal; Shashi Shekhar Suman; Shadab Anwar; Krishn Pratap Singh; Amir Zaidi; Abul Hasan Sardar; Pradeep Das; Vahab Ali
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

Review 8.  Leishmania spp. Proteome Data Sets: A Comprehensive Resource for Vaccine Development to Target Visceral Leishmaniasis.

Authors:  Toni Aebischer
Journal:  Front Immunol       Date:  2014-06-10       Impact factor: 7.561

Review 9.  Deception and manipulation: the arms of leishmania, a successful parasite.

Authors:  Pedro Cecílio; Begoña Pérez-Cabezas; Nuno Santarém; Joana Maciel; Vasco Rodrigues; Anabela Cordeiro da Silva
Journal:  Front Immunol       Date:  2014-10-20       Impact factor: 7.561

10.  Metabolic reprogramming during purine stress in the protozoan pathogen Leishmania donovani.

Authors:  Jessica L Martin; Phillip A Yates; Radika Soysa; Joshua F Alfaro; Feng Yang; Kristin E Burnum-Johnson; Vladislav A Petyuk; Karl K Weitz; David G Camp; Richard D Smith; Phillip A Wilmarth; Larry L David; Gowthaman Ramasamy; Peter J Myler; Nicola S Carter
Journal:  PLoS Pathog       Date:  2014-02-27       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.